Search Results - "Margol, Ashley S."
-
1
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas
Published in Science translational medicine (23-11-2016)“…Childhood posterior fossa (PF) ependymomas cause substantial morbidity and mortality. These tumors lack recurrent genetic mutations, but a subset of these…”
Get more information
Journal Article -
2
Tumor-associated macrophages in SHH subgroup of medulloblastomas
Published in Clinical cancer research (15-03-2015)“…Medulloblastoma in children can be categorized into at least four molecular subgroups, offering the potential for targeted therapeutic approaches to reduce…”
Get full text
Journal Article -
3
Pathology and diagnosis of SMARCB1-deficient tumors
Published in Cancer genetics (01-09-2014)“…Malignant rhabdoid tumor (MRT) can occur in the kidney, central nervous system, or extracranial/extrarenal locations and is characterized by alterations in the…”
Get full text
Journal Article -
4
Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
Published in Oncotarget (11-01-2019)“…Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive treatment strategies. The use of targeted therapy for BRAFV600E mutated…”
Get full text
Journal Article -
5
Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics
Published in Pediatric blood & cancer (01-12-2020)Get full text
Journal Article -
6
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials
Published in Journal of clinical oncology (20-04-2024)“…Why, when, and how to consider external control cohorts in pediatric brain tumor clinical trials…”
Get full text
Journal Article -
7
Pediatric Central Nervous System Embryonal Tumors: Presentation, Diagnosis, Therapeutic Strategies, and Survivorship—A Review
Published in Pediatric neurology (01-12-2024)“…Central nervous system (CNS) embryonal tumors represent a diverse group of neoplasms and have a peak incidence in early childhood. These tumors can be located…”
Get full text
Journal Article -
8
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma
Published in Neuro-oncology (Charlottesville, Va.) (02-11-2022)“…The prognosis for patients with pediatric high-grade glioma (pHGG) is poor despite aggressive multimodal therapy. Objective responses to targeted therapy with…”
Get full text
Journal Article -
9
MR multitasking‐based dynamic imaging for cerebrovascular evaluation ( MT‐DICE ): Simultaneous quantification of permeability and leakage‐insensitive perfusion by dynamic T1/T2 mapping
Published in Magnetic resonance in medicine (01-01-2023)“…Purpose To develop an MR multitasking‐based dynamic imaging for cerebrovascular evaluation (MT‐DICE) technique for simultaneous quantification of permeability…”
Get full text
Journal Article -
10
Clinical and neuropsychological outcome of pediatric non‐midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience
Published in Pediatric blood & cancer (01-12-2019)“…Background Germ cell tumors (GCT) arising from non‐midline structures (basal ganglia, thalamus, and posterior fossa) are rare. Although patients with midline…”
Get full text
Journal Article -
11
A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children’s Oncology Group
Published in Journal of neuro-oncology (01-12-2018)“…Background For several types of cancer, biological differences and outcome disparities have been documented in adolescents/young adults (AYAs, 15–39 years old)…”
Get full text
Journal Article -
12
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens
Published in Journal of neuro-oncology (01-11-2019)“…Purpose Irradiation-avoiding strategies have been used with relative success in the treatment of infants and young children with medulloblastoma. While…”
Get full text
Journal Article -
13
Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy
Published in Neuro-oncology (Charlottesville, Va.) (01-01-2016)“…Medulloblastomas in children can be categorized into 4 molecular subgroups with differing clinical characteristics, such that subgroup determination aids in…”
Get full text
Journal Article -
14
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients
Published in Neuro-oncology (Charlottesville, Va.) (31-07-2024)“…The frequency and significance of IDH mutations in glioma across age groups is incompletely understood. We performed a multi-center retrospective…”
Get full text
Journal Article -
15
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics
Published in Neuro-oncology (Charlottesville, Va.) (05-01-2023)“…The incidence and biology of IDH1/2 mutations in pediatric gliomas are unclear. Notably, current treatment approaches by pediatric and adult providers vary…”
Get full text
Journal Article -
16
Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
Published in Oncotarget (19-05-2023)Get full text
Journal Article -
17
Multi‐institutional analysis of central nervous system germ cell tumors in patients with Down syndrome
Published in Pediatric blood & cancer (01-10-2022)“…Purpose Primary germ cell tumors (GCTs) are the most common central nervous system (CNS) neoplasm in patients with Down syndrome (DS). However, a standard of…”
Get full text
Journal Article -
18
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors
Published in Journal of neuro-oncology (01-05-2018)“…Single agent studies targeting the tumor microenvironment in central nervous system (CNS) tumors have largely been disappointing. Combination therapies…”
Get full text
Journal Article -
19
Effective re-induction regimen for children with recurrent medulloblastoma
Published in Neuro-oncology advances (10-05-2024)“…Abstract Background There is no standard treatment for the recurrence of medulloblastoma, the most common malignant childhood brain tumor, and prognosis…”
Get full text
Journal Article -
20
A genome-wide association study on medulloblastoma
Published in Journal of neuro-oncology (01-04-2020)“…Introduction Medulloblastoma is a malignant embryonal tumor of the cerebellum that occurs predominantly in children. To find germline genetic variants…”
Get full text
Journal Article